High-density lipoprotein subclasses and their relationship to cardiovascular disease

Journal of Clinical Lipidology

Volumn 6, Issue 6, 2012, Pages 496-523

  Superko, H Robert ^b,c,d   Pendyala, Lakshmana ^e   Williams, Paul T ^f   Momary, Katherine M ^a,b   King III, Spencer B ^a,b   Garrett, Brenda C ^d  

^a Saint Joseph's Translational Research Institute   (United States)

^b MERCER UNIVERSITY   (United States)

^c CELERA   (United States)

^d Cholesterol Genetics and Heart Disease Institute   (United States)

^e University of Louisville School of Medicine   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analytic ultracentrifugation; Cardiovascular disease; Gradient gel electrophoresis; HDL subspecies; HDL2; HDL3; High density lipoprotein; Lipoprotein heterogeneity; Lipoprotein subclass; Two dimensional gel electrophoresis

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 2 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN 3 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GEL ELECTROPHORESIS; GRADIENT GEL ELECTROPHORESIS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; PARTICLE SIZE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; HUMANS; LIPOPROTEINS, HDL; MAGNETIC RESONANCE SPECTROSCOPY; ODDS RATIO; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84870291668     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.03.001     Document Type: Review

References (139)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High-density lipoprotein as a protective factor against coronary heart disease: The Framingham Heart Study Am J Med 62 1977 707 714
3. Multiple Risk Factor Intervention Trial Research Group Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial Prev Med 15 1986 254 273
4. D.J. Gordon, J. Knoke, J.L. Probstfield, R. Superko, H.A. Tyroler for the Lipid Research Clinics Program High density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial Circulation 74 1986 1217 1225
5. D.J. Gordon, J.L. Probstfield, and R.J. Carrison High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 1989 8 15
6. P.A. Romm, C.E. Green, K. Reagan, and C.E. Rackley Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease Am J Cardiol 67 1991 479 483
7. H. Drexel, F.W. Amann, and K. Rentsch Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease Am J Cardiol 70 1992 436 440
8. J.J. Badimon, L. Badimon, and V. Fuster Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit J Clin Invest 85 1990 1234 1241
9. E.M. Rubin, R.M. Krauss, E.A. Spangler, J.G. Verstuyft, and S.M. Clift Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 1991 265 267
10. R.S. Rosenson, H.B. Brewer Jr., and M.J. Chapman HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events Clin Chem 57 2011 392 410
11. H.R. Superko Lipid Altering Drugs LDL/HDL subclass Distribution. Match the Treatment to the Disorder ACC Curr J Rev 9 3 2000 18 24
12. P.J. Blanche, E.L. Gong, T.M. Forte, and A.V. Nichols Characterization of human high-density lipoproteins by gradient gel electrophoresis Biochim Biophys Acta 665 1981 408 419
13. F.T. Lindgren, L.C. Jensen, and F.T. Hatach The isolation and quantitative analysis of serum lipoproteins G.J. Nelson, Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism 1972 John Wiley New York 181 274
14. O.F. DeLalla, and J.W. Gofman Ultracentrifugal analysis of serum lipoproteins Methods Biochem Anal 1 1954 459 478
15. S. Eisenberg High density lipoprotein metabolism J Lipid Res 25 1984 1017 1058
16. P.T. Williams, R.M. Krauss, K.M. Vranizan, M.L. Stefanick, P.D. Wood, and F.T. Lindgren Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women Arterioscler Thromb 12 1992 332 340
17. R. Movva, and D.J. Rader Laboratory assessment of HDL heterogeneity and function Ann Biol Clin (Paris) 67 2009 7 21
18. Available at: http://www.nicholsinstitute.com/TestDetail.aspx?TestID= 2289. Accessed Feb 6, 2012.
19. Available at: http://www.liposcience.com/. Accessed Feb 6, 2012.
20. Available at: http://www.atherotech.com/. Accessed Feb 6, 2012.
21. Available at: http://www.bhlinc.com/. Accessed Feb 6, 2012.
22. Available at: http://www.bostonheartlab.com/. Accessed Feb 6, 2012.
23. H.R. Superko Advanced lipoprotein testing and subfractionation: research tool or clinical utility? Circulation 119 2009 2383 2395
24. J.L. Johnson, C.A. Slentz, and B.D. Duscha Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study Atherosclerosis 176 2004 371 377
25. N.E. Miller, F. Hammett, and S. Saltissi Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins Br Med J (Clin Res Ed) 282 1981 1741 1744
26. L.I. Gidez, G.J. Miller, M. Burstein, S. Slagle, and H.A. Eder Separation and quantification of subclasses of human plasma high density lipoproteins by a simple precipitation procedure J Lipid Res 23 1982 1206 1223
27. P.N. Demacker, D.F. van Sommeren-Zondag, A.F. Stalenhoef, P.M. Stuyt, and A. van't Laar Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3 Clin Chem 29 1983 656 663
28. J.D. Otvos, E.J. Jeyarajah, Bennett, and R.M. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin Chem 38 1992 1632 1638
29. M.C. Cheung, B.G. Brown, A.C. Wolf, and J.J. Albers Altered particle size distribution of apolipoprotein A-I containing lipoproteins in subjects with coronary artery disease J Lipid Res 32 1991 383 394
30. M. Okazaki, S. Usui, and S. Hosaki Analysis of plasma lipoproteins by gel permeation chromatography N. Rifal, G.R. Warnick, M.H. Dominiczak, Handbook of Lipoprotein Testing 2000 AACC Press Washington, DC 661
31. M.P. Caulfield, S. Li, and G. Lee Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis Clin Chem 54 2008 1307 1316
32. A.V. Nichols, P.J. Blanche, V.G. Shore, and E.L. Gong Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma Biochim Biophys Acta 1001 1989 325 337
33. B.F. Asztalos, C.H. Sloop, L. Wong, and P.S. Roheim Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations Biochim Biophys Acta 1169 1993 291 300
34. J. Johansson, P. Nilsson-Ehle, L.A. Carlson, and A. Hamsten The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age Atherosclerosis 86 1991 111 122
35. L.I. Katzel, P.J. Coon, M.J. Busby, S.O. Gottlieb, R.M. Krauss, and A.P. Goldberg Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia Arterioscler Thromb 12 1992 814 823
36. B.J. Arsenault, I. Lemieux, and J.P. Després Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size Clin Chem 56 2010 789 798
37. C. Alagona, A. Soro, K. Ylitalo, R. Salonen, J.T. Salonen, and M.R. Taskinen A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families Atherosclerosis 165 2002 309 316
38. V. Atger, P. Giral, and A. Simon High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medicine du Travail Am J Cardiol 75 1995 127 131
39. C. Breier, V. Muhlberger, and H. Drexel Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease Lancet 1 1985 1242 1244
40. H. Drexel, F.W. Amann, and J. Beran Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis Circulation 90 1994 2230 2235
41. H. Drexel, J. Steurer, and J. Muntwyler Predictors of the presence and extent of peripheral arterial occlusive disease Circulation 94 Suppl II 1996 199 205
42. B. Föger, G. Luef, and A. Ritsch Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness J Mol Med 73 1995 369 372
43. D.S. Freedman, J.D. Otvos, E.J. Jeyarajah, J.J. Barboriak, A.J. Anderson, and J.A. Walker Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease Arterioscler Thromb Vasc Biol 18 1998 1046 1053
44. P. Giral, V. Atger, and J. Amar A relationship between aortic stiffness and serum HDL3 cholesterol concentrations in hypercholesterolaemic, symptom-free men. The PCVMETRA Group (Groupe de Prévention Cardiovasculaire en Médicine du Travail) J Cardiovasc Risk 1 1994 53 58
45. N. Jayakumari, K. Raghu, V.A. Kumari, K.G. Balakrishnan, and K.S. Iyer Distribution of cholesterol in HDL and its subfractions in patients with coronary atherosclerotic heart disease Indian Heart J 45 1993 265 268
46. D. Jiang, D. Wen, and S. Qi The significance of high-density lipoprotein subfractions and triglycerides in predicting coronary artery disease Zhonghua Nei Ke Za Zhi 34 1995 298 301
47. H.J. Kempen, C.M. van Gent, R. Buytenhek, and B. Buis Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function J Lab Clin Med 109 1987 19 26
48. S. Lamon-Fava, D.M. Herrington, and D.M. Reboussin Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women Arterioscler Thromb Vasc Biol 28 2008 575 579
49. R.I. Levy, J.F. Brensike, and S.E. Epstein Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study Circulation 69 1984 313 324
50. S. Maeda, S. Nakanishi, and M. Yoneda Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans J Atheroscler Thromb 19 2012 444 452
51. M. Mänttäri, J.K. Huttunen, and P. Koskinen Lipoproteins and coronary heart disease in the Helsinki Heart Study Eur Heart J 11 1990 26 31
52. J.J. O'Sullivan, A. Matthew, R.M. Conroy, R.J. Erwin, and P.F. Duggan Relation of angiographically defined coronary artery disease to serum lipoprotein levels Clin Cardiol 13 1990 841 844
53. C.M. Smuts, H.F. Weich, and M.J. Weight Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease Coron Artery Dis 5 1994 331 338
54. P. Tornvall, F. Karpe, and A. Proudler High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease Metabolism 45 1996 1375 1382
55. H. Watanabe, S. Söderlund, and A. Soro-Paavonen Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness Arterioscler Thromb Vasc Biol 26 2006 897 902
56. C. Alessandri, F. Violi, and E. De Marzio Blood lipid abnormalities in patients suffering from peripheral vascular disease Int Angiol 7 1988 263 265
57. N. Al-Muhtaseb, and A.R. Al-Yousuf Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction Ann Saudi Med 12 1992 252 258
58. B.R. Asztalos, P.S. Roheim, and R.L. Milani Distribution of ApoA-I containing HDL subpopulations in patients with coronary heart disease Arterioscler Thromb Vasc Biol 20 2000 2670 2676
59. B.F. Asztalos, L.A. Cupples, and S. Demissie High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham offspring study Arterioscler Thromb Vasc Biol 24 2004 2181 2187
60. P. Avogaro, G. Cazzolato, G.B. Bon, and F. Belussi Levels and chemical composition of HDL2, HDL3, and other major lipoprotein classes in survivors of myocardial infarction Artery 5 1979 495 508
61. M.C. Bakogianni, C.A. Kalofoutis, K.I. Skenderi, and A.T. Kalofoutis Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease J Diabetes Complications 15 2001 265 269
62. F.C. Ballantyne, R.S. Clark, H.S. Simpson, and D. Ballantyne High density and low density subfractions in survivors of myocardial infarction and in control subjects Metabolism 31 1982 433 437
63. J.G. Brook, M. Aviram, A. Viener, E. Shilansky, and W. Markiewicz High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis Circulation 66 1982 923 926
64. J.E. Buring, G.T. O'Connor, and S.Z. Goldhaber Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction Circulation 85 1992 22 29
65. L. Calabresi, G. Franceschini, M. Sirtori, G. Gianfranceschi, P. Werba, and C.R. Sirtori Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease Atherosclerosis 84 1990 41 48
66. H. Campos, G.O. Roederer, S. Lussier-Cacan, J. Davignon, and R.M. Krauss Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease Arterioscler Thromb Vasc Biol 15 1995 1043 1048
67. J.M. Chemnitius, H. Winkel, and I. Meyer Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease Med Klin (Munich) 93 1998 137 145
68. M.C. Cheung, B.G. Brown, A.C. Wolf, and J.J. Albers Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease J Lipid Res 32 1991 383 394
69. A.K. Diehl, J.H. Fuller, M.B. Mattock, A.M. Salter, R. el-Gohari, and H. Keen The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease Atherosclerosis 69 1988 145 153
70. R. Fellin, L. Baroni, M.R. Baiocchi, G. Baldo Enzi, F. Grego, and G. Valerio Selective determination of cholesterol in high density lipoprotein subfractions (HDL2 and HDL3) in patients with cerebral and peripheral arteriosclerosis Clin Chim Acta 147 1985 233 240
71. G. Franceschini, A. Bondioli, D. Granata, V. Mercuri, M. Negri, C. Tosi, and C.R. Sirtori Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis Atherosclerosis 68 1987 213 219
72. J.M. Gaziano, J.E. Buring, and J.L. Breslow Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction N Engl J Med 329 1993 1829 1834
73. A. Hamsten, G. Walldius, G. Dahlen, B. Johansson, and U. De Faire Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction Atherosclerosis 59 1986 223 235
74. J. Kahri, M. Syvänne, and M.R. Taskinen Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease Metabolism 43 1994 1498 1502
75. A. Kalofoutis, A. Papapanagiotou, and M. Tzivras Clinical significance of plasma HDL subfractions (HDL2, HDL3) in patients with peripheral arterial disease (PAD) in the Greek population Clin Biochem 32 1999 149 152
76. R. Kauppinen-Makelin, and E.A. Nikkila Serum lipoproteins in patients with myocardial infarction Atherosclerosis 74 1988 65 74
77. M. Laakso, E. Voutilainen, K. Pyorala, and H. Sarlund Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics Arteriosclerosis 5 1985 653 658
78. P. Marques-Vidal, J.B. Ruidavets, and J.P. Cambou Distribution, fatty acid composition and apolipoprotein A-I immunoreactivity of high density lipoprotein subfractions in myocardial infarction Atherosclerosis 112 1995 29 38
79. B.F. Mowat, E.R. Skinner, H.M. Wilson, G.C. Leng, F.G. Fowkes, and D. Horrobin Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease Atherosclerosis 131 1997 161 166
80. O. Mueller, E. Chang, and D. Deng PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfraction is independent of HDL cholesterol Clin Chem Lab Med 46 2008 490 498
81. H.K. Naito The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography Ann N Y Acad Sci 454 1985 230 238
82. G. Nowicka, and A. Jarosz LpAI in HDL subfractions: serum levels in men and women with coronary heart disease and changes under hypolipemic therapy Clin Chim Acta 306 2001 43 49
83. S.B. Schmidt, A.G. Wasserman, R.A. Muesing, S.E. Schlesselman, J.C. Larosa, and A.M. Ross Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis Am J Cardiol 55 13 Pt 1 1985 1459 1462
84. H.J. Steenkamp, P.L. Jooste, A.J. Benade, M.L. Langenhoven, and J.E. Rossouw Relationship between high density lipoprotein subfractions and coronary risk factors in a rural white population Arteriosclerosis 10 1990 1026 1031
85. M. Syvänne, J. Kahri, K.S. Virtanen, and M.R. Taskinen HDLs containing apolipoproteins A-I and A-II (LpA-I: A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus Circulation 92 1995 364 370
86. G.B. Vigna, M. Bolzan, and F. Romagnoni Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis Circulation 85 1992 2205 2211
87. E. Vitale, G. Zuliani, and L. Baroni Lipoprotein abnormalities in patients with extra-coronary arteriosclerosis Atherosclerosis 81 1990 95 102
88. L. Wallentin, and B. Sundin HDL2 and HDL3 lipid levels in coronary artery disease Atherosclerosis 59 1986 131 136
89. H.M. Wilson, J.C. Patel, D. Russell, and E.R. Skinner Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease Clin Chim Acta 220 1993 175 187
90. M. Zeman, and A. Zák Indicators of lipoprotein metabolism in normolipemic men after myocardial infarct [in Czeck] Cas Lek Cesk 134 1995 577 579
91. M. Zeman, A. Zák, and E. Tvrzická Indices of plasma lipoprotein metabolism in normolipidemic myocardial infarction survivors Sb Lek 96 1995 269 274
92. B.R. Asztalos, D. Collins, and L.A. Cupples Value of HDL subpopulation in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial Arterioscler Thromb Vasc Biol 25 2005 2185 2191
93. K. El Harchaoui, B.J. Arsenault, and R. Franssen High-density lipoprotein particle size and concentration and coronary risk Ann Intern Med 150 2009 84 93
94. W.Y. Fujimoto, R.W. Bergstrom, and E.J. Boyko Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study Diabetes Care 22 1999 1808 1812
95. J.W. Gofman, W. Young, and R. Tandy Ischemic heart disease, atherosclerosis, and longevity Circulation 34 1966 679 697
96. M. Laakso, S. Lehto, I. Penttilä, and K. Pyörälä Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes Circulation 88 1993 1421 1430
97. B. Lamarche, S. Moorjani, B. Cantin, G.R. Dagenais, P.J. Lupien, and J.P. Després Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study Arterioscler Thromb Vasc Biol 17 1997 1098 1105
98. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, and P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 939
99. K. Musunuru, M. Orho-Melander, and M.P. Caulfield Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk Arterioscler Thromb Vasc Biol 29 2009 1975 1980
100. J.D. Otvos, D. Collins, and D.S. Freedman Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563
101. J.T. Salonen, R. Salonen, K. Seppänen, R. Rauramaa, and J. Tuomilehto HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men Circulation 84 1991 129 139
102. A.R. Sharrett, C.M. Ballantyne, and S.A. Coady Atherosclerosis Risk in Communities Study Group Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study Circulation 104 2001 1108 1113
103. M.J. Stampfer, F.M. Sacks, S. Salvini, W.C. Willett, and C.H. Hennekens A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N Engl J Med 325 1991 373 381
104. P.M. Sweetnam, C.H. Bolton, and J.W. Yarnell Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies Circulation 90 1994 769 774
105. P.T. Williams, and D.E. Feldman Prospective study of coronary heart disease vs HDL2, HDL3, and other lipoproteins in Gofman's Livermore cohort Atherosclerosis 214 2011 196 202
106. P.T. Williams Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's Livermore Cohort J Lipid Res 53 2012 266 272
107. B.R. Asztalos, M. Batista, and K.V. Horvath Change in a1 HDL concentration predicts progression in coronary artery stenosis Arterioscler Thromb Vasc Biol 23 2003 847 852
108. B.G. Brown, X.Q. Zhao, and A. Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592
109. J. Johansson, L.A. Carlson, C. Landou, and A. Hamsten High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients Arterioscler Thromb 11 1991 174 182
110. J. Johansson, A.G. Olsson, and L. Bergstrand Lowering of HDL2b by Probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report Arterioscler Thromb Vasc Biol 15 1995 1049 1056
111. S. Lamon-Fava, D.M. Herrington, and D.M. Reboussin Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women Arterioscler Thromb Vasc Biol 28 2008 575 579
112. R.S. Rosenson, J.D. Otvos, and D.S. Freedman Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial Am J Cardiol 90 2002 89 94
113. S.M. Grundy, G.L. Vega, J.D. Otvos, D.L. Rainwater, and J.C. Cohen Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence J Lipid Res 40 1999 229 234
114. C.H. Azevedo, M. Wajngarten, A.C. Prete, J. Diament, and R.C. Maranhão Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease Clinics (Sao Paulo) 66 9 2011 1543 1548
115. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 1992 242 250
116. G. Franceschini, C. Tosi, Y. Moreno, and C.R. Sirtori Effects of storage on the distribution of high density lipoprotein subfractions in human sera J Lipid Res 26 1985 1368 1373
117. W.H. Daerr, E.E. Windler, H.D. Rohwer, and H. Greten Limitations of a new double-precipitation method for the determination of high density lipoprotein subfractions 2 and 3 Atherosclerosis 49 1983 211 213
118. E.M. deGoma, R.L. deGoma, and D.J. Rader Beyond high-density lipoprotein cholesterol levels J Am Coll Cardiol 51 2008 2199 2211
119. J.E. Feig, R. Shamir, and E.A. Fisher Atheroprotective effects of HDL: beyond reverse cholesterol transport Curr Drug Targets 9 2008 196 203
120. O. Stein, and Y. Stein Atheroprotective mechanisms of HDL Atherosclerosis 144 1999 285 301
121. G. Assmann, and J.R. Nofer Atheroprotective effects of high-density lipoproteins Annu Rev Med 54 2003 321 341
122. A.V. Khera, M. Cuchel, and M. de la Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
123. M. Cuchel, and D.J. Rader Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113 2006 2548 2555
124. M.A. Kennedy, G.C. Barrera, and K. Nakamura ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab 1 2005 121 131
125. N. Wang, D.L. Silver, P. Costet, and A.R. Tall Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1 J Biol Chem 275 2000 33053 33058
126. P. Linsel-Nitschke, H. Jansen, and Z. Aherrarhou Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography Lipids Health Dis 8 2009 14
127. Z. Julia, E. Duchene, and N. Fournier Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia J Lipid Res 51 2010 3350 3358
128. N. Bellanger, A. Orsoni, and Z. Julia Atheroprotective reverse cholesterol transport pathway isdefective in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 31 2011 1675 1681
129. A.R. Tall Plasma high density lipoproteins. Metabolism and relationship to atherosclerosis J Clin Invest 86 1990 379 384
130. J. Frohlich, and M. Dobiásová Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography Clin Chem 49 2003 1873 1880
131. M. Dobiasova, J. Stribrna, P.H. Prichard, and J.J. Frohlich Cholesterol esterification rate in plasma depleted of very low and low density lipoprotein is controlled by the proportion of HDL2 and HDL3 subclasses: subclasses: study in hypertensive and normal middle-aged and septuagenarian men J Lipid Res 33 1992 1411 1418
132. N. Shuhei, S. Söderlund, M. Jauhiainen, and M.R. Taskinen Effect of HDL composition and particle size on the resistance of HDL to the oxidation Lipids Health Dis 9 2010 104
133. A. Kontush, S. Chantepie, and M.J. Chapman Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler Thromb Vasc Biol 23 2003 1881 1888
134. AIM-HIGH Investigators, W.E. Boden, J.L. Probstfield, and T. Anderson Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
135. P.J. Barter, M. Caulfield, and M. Eriksson Effects of Torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
136. G. Catalano, Z. Julia, and E. Frisdal Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway Arterioscler Thromb Vasc Biol 29 2009 268 275
137. R.M. Krauss, K. Wojnooski, and J. Orr Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the cholesteryl ester transfer protein inhibitor anacetrapib J Lipid Res 53 2012 540 547
138. C.P. Cannon, S. Shah, H.M. Dansky Determining the Efficacy and Tolerability Investigators Safety of anacetrapib in patients with or at high risk for coronary heart disease N Engl J Med 363 2010 2406 2415
139. P.T. Williams, R.M. Krauss, K.M. Vranizan, and P.D. Wood Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men Circulation 81 1990 1293 1304